We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-13.86%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.39B
AUM Growth
+$23.5M
Cap. Flow
+$245M
Cap. Flow %
17.64%
Top 10 Hldgs %
24.95%
Holding
4,841
New
999
Increased
1,367
Reduced
1,469
Closed
908

Sector Composition

Rank Sector Weight
1 Healthcare 6.26%
2 Financials 5.86%
3 Technology 5.03%
4 Energy 4.85%
5 Consumer Discretionary 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TAP icon
1101
Molson Coors Class B
TAP
$8.1B
$73K 0.01%
1,297
-6,838
-84% -$421K
WEN icon
1102
Wendy's
WEN
$1.46B
$73K 0.01%
4,646
-47,901
-91% -$817K
SGI
1103
Somnigroup International
SGI
$13.7B
$73K 0.01%
7,088
-9,220
-57% -$110K
SWN
1104
DELISTED
Southwestern Energy Company
SWN
$73K 0.01%
21,638
-16,116
-43% -$79.3K
DSKE
1105
DELISTED
Daseke, Inc. Common Stock
DSKE
$73K 0.01%
19,744
+17,330
+718% +$92.8K
TLRD
1106
DELISTED
Tailored Brands, Inc.
TLRD
$73K 0.01%
5,342
+691
+15% +$14.2K
MACK
1107
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$73K 0.01%
24,229
+3,857
+19% +$13.4K
ABEV icon
1108
Ambev
ABEV
$46.4B
$72K 0.01%
18,381
-108,963
-86% -$465K
ESLT icon
1109
Elbit Systems
ESLT
$40.3B
$72K 0.01%
634
+561
+768% +$68.1K
ILPT
1110
Industrial Logistics Properties Trust
ILPT
$586M
$72K 0.01%
+3,673
New +$78.4K
PTCT icon
1111
PTC Therapeutics
PTCT
$6.12B
$72K 0.01%
+2,106
New +$75.7K
USFD icon
1112
US Foods
USFD
$24B
$72K 0.01%
2,272
-1,728
-43% -$53.3K
ODT
1113
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$72K 0.01%
5,157
-131
-2% -$2.04K
HRC
1114
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$72K 0.01%
818
-5,315
-87% -$483K
CBL
1115
DELISTED
CBL& Associates Properties, Inc.
CBL
$72K 0.01%
+37,319
New +$109K
GARS
1116
DELISTED
Garrison Capital Inc.
GARS
$72K 0.01%
11,293
+6,289
+126% +$47.7K
APTI
1117
DELISTED
Apptio, Inc. Class A Common Stock
APTI
$72K 0.01%
+1,884
New +$63.7K
BFAM icon
1118
Bright Horizons
BFAM
$3.86B
$71K 0.01%
633
-69
-10% -$7.93K
CFR icon
1119
Cullen/Frost Bankers
CFR
$10.2B
$71K 0.01%
812
-3,072
-79% -$299K
CLGX
1120
DELISTED
Corelogic, Inc.
CLGX
$71K 0.01%
2,132
-8,435
-80% -$342K
AGEN
1121
Agenus
AGEN
$290M
$70K 0.01%
1,510
+1,088
+258% +$45.4K
DMRC icon
1122
Digimarc Corp
DMRC
$178M
$70K 0.01%
+4,831
New +$106K
IT icon
1123
Gartner
IT
$11.7B
$70K 0.01%
547
+217
+66% +$31.3K
LEG icon
1124
Leggett & Platt
LEG
$1.31B
$70K 0.01%
1,971
+1,763
+848% +$67.1K
MBI icon
1125
MBIA
MBI
$260M
$70K 0.01%
7,840
+440
+6% +$4.19K

Similar funds

Tower Research Capital (TRC)'s Q4 2018 Portfolio in Review

As of Q4 2018, Tower Research Capital (TRC) held 4,841 positions worth $1.39B, up 1.7% from $1.36B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Tower Research Capital (TRC) deployed $245M of net new capital in Q4 2018, opening 999 new positions and adding to 1,367 existing holdings. Its largest new stake was iShares S&P 500 Value ETF: 55,235 shares worth $5.59M.

By sector, the portfolio is most concentrated in Healthcare at 6.3% of assets, down from 6.8% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $124M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2018 buy was iShares S&P 500 Value ETF: 55,235 shares worth $5.59M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2018, an estimated $123M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $124M.
  • Tower Research Capital (TRC) fully exited State Street Energy Select Sector SPDR ETF in Q4 2018, selling an estimated $26.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 25% of its $1.39B portfolio in Q4 2018.
  • Tower Research Capital (TRC) opened 999 new positions and closed 908 in Q4 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 1.7% quarter-over-quarter to $1.39B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2018, filed 14 Feb 2019.